These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 33472449)
1. Progress and new horizons toward a VAR2CSA-based placental malaria vaccine. Doritchamou JYA; Suurbaar J; Tuikue Ndam N Expert Rev Vaccines; 2021 Feb; 20(2):215-226. PubMed ID: 33472449 [No Abstract] [Full Text] [Related]
2. Progress and Insights Toward an Effective Placental Malaria Vaccine. Gamain B; Chêne A; Viebig NK; Tuikue Ndam N; Nielsen MA Front Immunol; 2021; 12():634508. PubMed ID: 33717176 [TBL] [Abstract][Full Text] [Related]
3. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design. Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695 [TBL] [Abstract][Full Text] [Related]
4. Designing a VAR2CSA-based vaccine to prevent placental malaria. Fried M; Duffy PE Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717 [TBL] [Abstract][Full Text] [Related]
5. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA. Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946 [TBL] [Abstract][Full Text] [Related]
6. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria. Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604 [TBL] [Abstract][Full Text] [Related]
8. Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development. Benavente ED; Oresegun DR; de Sessions PF; Walker EM; Roper C; Dombrowski JG; de Souza RM; Marinho CRF; Sutherland CJ; Hibberd ML; Mohareb F; Baker DA; Clark TG; Campino S Sci Rep; 2018 Oct; 8(1):15429. PubMed ID: 30337594 [TBL] [Abstract][Full Text] [Related]
9. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for placental malaria. Bordbar B; Tuikue Ndam N; Renard E; Jafari-Guemouri S; Tavul L; Jennison C; Gnidehou S; Tahar R; Gamboa D; Bendezu J; Menard D; Barry AE; Deloron P; Sabbagh A Infect Genet Evol; 2014 Jul; 25():81-92. PubMed ID: 24768682 [TBL] [Abstract][Full Text] [Related]
10. Preclinical immunogenicity and safety of the cGMP-grade placental malaria vaccine PRIMVAC. Chêne A; Gangnard S; Guadall A; Ginisty H; Leroy O; Havelange N; Viebig NK; Gamain B EBioMedicine; 2019 Apr; 42():145-156. PubMed ID: 30885725 [TBL] [Abstract][Full Text] [Related]
11. The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine. Nielsen MA; Resende M; de Jongh WA; Ditlev SB; Mordmüller B; Houard S; Ndam NT; Agerbæk MØ; Hamborg M; Massougbodji A; Issifou S; Strøbæk A; Poulsen L; Leroy O; Kremsner PG; Chippaux JP; Luty AJ; Deloron P; Theander TG; Dyring C; Salanti A PLoS One; 2015; 10(9):e0135406. PubMed ID: 26327283 [TBL] [Abstract][Full Text] [Related]
12. Structural insights into global mutations in the ligand-binding domain of VAR2CSA and its implications on placental malaria vaccine. Gill J; Chakraborti S; Bharti P; Sharma A Int J Infect Dis; 2021 Nov; 112():35-39. PubMed ID: 34450283 [TBL] [Abstract][Full Text] [Related]
13. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains. Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524 [TBL] [Abstract][Full Text] [Related]
14. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions. Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557 [TBL] [Abstract][Full Text] [Related]
15. Towards a vaccine against pregnancy-associated malaria. Tuikue Ndam N; Deloron P Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733 [TBL] [Abstract][Full Text] [Related]